Cargando…

The use of recombinant factor VIIa as a haemostatic agent in ICU patients

Detalles Bibliográficos
Autores principales:	Vernikos, P, Xanthis, D, Georgiou, S, Archontoulis, N, Mega, A, Rigas, K, Pavleas, J, Katsarou, O, Thomopoulos, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099722/ http://dx.doi.org/10.1186/cc2602

Ejemplares similares

1036. Comparison of the hemodynamic parameters of two external chest compression devices (LUCAS versus AUTOPULSE) in a swine model of ventricular fibrillation
por: Pantazopoulos, C, et al.
Publicado: (2014)

0391. Comparison of the histopathologic effects on the lungs of two external chest compression devices (lucas versus autopulse) in a swine model of ventricular fibrillation
por: Pantazopoulos, C, et al.
Publicado: (2014)

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period
por: Skiada, A, et al.
Publicado: (2008)

Systemic rheumatic diseases in the ICU
por: Vernikos, P, et al.
Publicado: (2009)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage
por: Chou, S, et al.
Publicado: (2011)

Assessment of rVIIa as a universal haemostatic agent in a model of haemodilution
por: Chillala, S, et al.
Publicado: (2001)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Does recombinant factor VIIa change the inflammatory response to trauma? Preliminary results of inflammatory biomarkers in critically ill trauma patients
por: Lissauer, M, et al.
Publicado: (2006)

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007)

Comparative study between fluidless resuscitation with permissive hypotension using the impedance threshold device versus aggressive fluid resuscitation with Ringer lactate in a swine model of hemorrhagic shock
por: Pantazopoulos, C, et al.
Publicado: (2015)

Prospective nonrandomized observational study of the use of an impedance threshold device in patients with spontaneous respiration and hemodynamic instability
por: Pantazopoulos, C, et al.
Publicado: (2015)

Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005)

Early use of factor VIIa in cardiac surgery is associated with lower rates of blood transfusions without impact on outcome
por: Galas, F, et al.
Publicado: (2010)

Hæmostatic Agents
Publicado: (1856)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand
por: Mehta, Darshan A., et al.
Publicado: (2016)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008)

Recombinant factor VIIa in severe trauma: further study needed
por: Galvan, Dan A, et al.
Publicado: (2006)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008)

Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas
por: Koh, Young Rae, et al.
Publicado: (2012)

Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
por: Mohr, Alicia M, et al.
Publicado: (2005)

Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
por: Puetz, John
Publicado: (2010)

Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis
por: Yaghi, Shadi, et al.
Publicado: (2015)

Risk factor of withdrawal syndrome in the paediatric ICU
por: Tanaka, C, et al.
Publicado: (2014)

Analysis of the stressful factors in an ICU
por: Albuquerque, LC, et al.
Publicado: (2005)

Haemostatic activation markers in brain injury for mortality prediction: comparison of blood samples from the jugular bulb and central venous line
por: Baffoun, N, et al.
Publicado: (2007)

The risk factors for developing exposure keratopathy in ICU patients
por: Kousha, O, et al.
Publicado: (2015)

Incidence and risk factors of hypertriglyceridemia in the ICU
por: Shams, MR, et al.
Publicado: (2009)

Factor VIIa for severe cardiac surgical bleeding
por: Diprose, P, et al.
Publicado: (2002)

Recombinant Factor VIIa in Post-partum Hemorrhage: A New Weapon in Obstetrician's Armamentarium
por: Magon, Navneet, et al.
Publicado: (2012)

Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings
por: Grounds, R Michael, et al.
Publicado: (2005)

The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
por: Lin, Y, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6jdoc1sm7eggsoetudtch1bvns